{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:43:32Z","timestamp":1769640212771,"version":"3.49.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T00:00:00Z","timestamp":1485388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"NIH Lung Tissue Research Consortium","award":["08-99-0002"],"award-info":[{"award-number":["08-99-0002"]}]},{"name":"NIH NHLBI","award":["R01 HL088151"],"award-info":[{"award-number":["R01 HL088151"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0170606","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T21:48:55Z","timestamp":1485467335000},"page":"e0170606","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease"],"prefix":"10.1371","volume":"12","author":[{"given":"Anthony M.","family":"Szema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayyed A.","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonya","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Sabatini Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan M.","family":"Ramiro-Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wieslawa","family":"Giermakowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura V.","family":"Gonzalez Bosc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,1,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1097\/MCP.0000000000000084","article-title":"Pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis","volume":"20","author":"Y Adir","year":"2014","journal-title":"Current Opinion in Pulmonary Medicine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/15412550902754252","article-title":"Pulmonary Hypertension in COPD: A Review and Consideration of the Role of Arterial Vasodilators","volume":"6","author":"CD Burger","year":"2009","journal-title":"COPD"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev.immunol.15.1.707","article-title":"Transcription factors of the NFAT family: regulation and function","volume":"15","author":"A Rao","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"ref4","article-title":"NFATc3 Is Required for Chronic Hypoxia-induced Pulmonary Hypertension in Adult and Neonatal Mice","author":"R Bierer","year":"2011","journal-title":"American Journal of Physiology\u2014Lung Cellular and Molecular Physiology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1073\/pnas.0610467104","article-title":"The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted","volume":"104","author":"S Bonnet","year":"2007","journal-title":"PNAS"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"15081","DOI":"10.1074\/jbc.M702679200","article-title":"NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with alpha -actin up-regulation","volume":"282","author":"S De Frutos","year":"2007","journal-title":"J Biol Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"L475","DOI":"10.1152\/ajplung.00060.2009","article-title":"Regulation of soluble guanylyl cyclase-{alpha}1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR","volume":"297","author":"S De Frutos","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"47326","DOI":"10.1074\/jbc.M408789200","article-title":"NFATc3 regulates Kv2.1 expression in arterial smooth muscle","volume":"279","author":"GC Amberg","year":"2004","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1074\/jbc.M608822200","article-title":"Activation of NFATC3 down-regulates the beta 1 subunit of large conductance, calcium-activated K+ channels in arterial smooth muscle and contributes to hypertension","volume":"282","author":"M Nieves-Cintron","year":"2006","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.vph.2013.11.001","article-title":"Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivity","volume":"60","author":"JK Friedman","year":"2014","journal-title":"Vascular Pharmacology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"26113","DOI":"10.1074\/jbc.M411972200","article-title":"Nuclear Factor of Activated T-cells and Serum Response Factor cooperatively regulate an \u03b1-actin intronic enhancer","volume":"280","author":"LV Gonzalez Bosc","year":"2004","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.110.963314","article-title":"Signal transducers and activators of transcription-3\/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension","volume":"123","author":"R Paulin","year":"2011","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.celrep.2013.07.021","article-title":"The Calcineurin-NFAT-Angiopoietin-2 Signaling Axis in Lung Endothelium Is Critical for the Establishment of Lung Metastases","volume":"4","author":"T Minami","year":"2013","journal-title":"Cell Reports"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"29044","DOI":"10.1074\/jbc.M114.555235","article-title":"Genome-wide Approaches Reveal Functional Vascular Endothelial Growth Factor (VEGF)-inducible Nuclear Factor of Activated T Cells (NFAT) c1 Binding to Angiogenesis-related Genes in the Endothelium","volume":"289","author":"Suehiro Ji","year":"2014","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood-2010-12-322701","article-title":"NFATc3 regulates the transcription of genes involved in T-cell activation and angiogenesis","volume":"118","author":"K Urso","year":"2011","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pupt.2014.09.003","article-title":"Pulmonary vascular changes in asthma and COPD","volume":"29","author":"LM Harkness","year":"2014","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1378\/chest.11-1962","article-title":"Angiogenesis in pulmonary fibrosis: too much or not enough?","volume":"142","author":"C Hanumegowda","year":"2012","journal-title":"Chest"},{"key":"ref18","unstructured":"Hamidi SA, Szema AM, Said S (2008) A single pathogenetic mechanism for Vascular remodeling and inflammation in PAH. European Respiratory Society Annual Congress."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1196\/annals.1418.014","article-title":"The Vasoactive Intestinal Peptide Gene Is a Key Modulator of Pulmonary Vascular Remodeling and Inflammation","volume":"1144","author":"SI Said","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1152\/japplphysiol.00861.2013","article-title":"Role of VPAC2 receptor in monocrotaline-induced pulmonary hypertension in rats","volume":"117","author":"M Koga","year":"2014","journal-title":"J Appl Physiol"},{"key":"ref21","first-page":"1607","article-title":"Relaxant action of VIP on cat pulmonary artery: comparison with acetylcholine, isoproterenol, and PGE1","volume":"54","author":"Y Hamasaki","year":"1983","journal-title":"J Appl Physiol Respir Environ Exerc Physiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1465-9921-12-141","article-title":"VIP and endothelin receptor antagonist: An effective combination against experimental pulmonary arterial hypertension","volume":"12","author":"S Hamidi","year":"2011","journal-title":"Respiratory Research"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1152\/jappl.1985.58.5.1723","article-title":"Pulmonary vasodilator responses to vasoactive intestinal peptide in the cat","volume":"58","author":"PA Nandiwada","year":"1985","journal-title":"J Appl Physiol"},{"key":"ref24","first-page":"304","article-title":"Vasoactive intestinal peptide relaxes isolated strips of human bronchus, pulmonary artery, and lung parenchyma","volume":"97","author":"T Saga","year":"1984","journal-title":"Trans Assoc Am Physicians"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1749-6632.1998.tb11240.x","article-title":"Enhancement of Systemic and Pulmonary Vasoconstriction by \u03b2-Amyloid Peptides and its Suppression by Vasoactive Intestinal Peptide","volume":"865","author":"SI Said","year":"1998","journal-title":"Annals of the New York Academy of Sciences"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.peptides.2009.08.010","article-title":"Adenoviral transfer of vasoactive intestinal peptide (VIP) gene inhibits rat aortic and pulmonary artery smooth muscle cell proliferation","volume":"30","author":"RC Hilaire","year":"2009","journal-title":"Peptides"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI200317295","article-title":"Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling","volume":"111","author":"JC Braz","year":"2003","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"R939","DOI":"10.1152\/ajpregu.00200.2003","article-title":"Disrupted circadian rhythms in VIP- and PHI-deficient mice","volume":"285","author":"CS Colwell","year":"2003","journal-title":"American Journal of Physiology\u2014Regulatory, Integrative and Comparative Physiology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"H2382","DOI":"10.1152\/ajpheart.00132.2008","article-title":"NFATc3 is required for intermittent hypoxia-induced hypertension","volume":"294","author":"S De Frutos","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"C441","DOI":"10.1152\/ajpcell.00029.2011","article-title":"Endothelin-1 contributes to increased NFATc3 activation by chronic hypoxia in pulmonary arteries","volume":"301","author":"S De Frutos","year":"2011","journal-title":"American Journal of Physiology\u2014Cell Physiology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-pathol-012513-104706","article-title":"Pathogenesis of Idiopathic Pulmonary Fibrosis","volume":"9","author":"PJ Wolters","year":"2014","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1465-9921-13-3","article-title":"The pathogenesis of COPD and IPF: Distinct horns of the same devil?","volume":"13","author":"M Chilosi","year":"2012","journal-title":"Respir Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1096\/fasebj.30.1_supplement.746.7","article-title":"Effect of Hypoxia on Fibroblast Proliferation in Idiopathic Pulmonary Fibrosis","volume":"30","author":"LK Senavirathna","year":"2016","journal-title":"The FASEB Journal"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/01902149209031681","article-title":"Dynamic aspects of regulatory lung peptides in chronic hypoxic pulmonary hypertension","volume":"18","author":"IM Keith","year":"1992","journal-title":"Exp Lung Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1513\/pats.200504-045SR","article-title":"Pathogenesis of Chronic Obstructive Pulmonary Disease","volume":"2","author":"W MacNee","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1165\/rcmb.2012-0230OC","article-title":"Peripheral Blood Mononuclear Cell Gene Expression in Chronic Obstructive Pulmonary Disease","volume":"49","author":"TM Bahr","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1042\/CS20130152","article-title":"CRAC channel inhibition produces greater anti-inflammatory effects than glucocorticoids in COPD CD8 cells","volume":"126","author":"S Grundy","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1465-9921-14-2","article-title":"Silencing of STIM1 attenuates hypoxia-induced PASMCs proliferation via inhibition of the SOC\/Ca(2+)\/NFAT pathway","volume":"14","author":"X Hou","year":"2013","journal-title":"Respir Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI17500","article-title":"Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension","volume":"111","author":"V Petkov","year":"2003","journal-title":"The Journal of clinical investigation"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0170606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T02:49:55Z","timestamp":1719024595000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0170606"}},"subtitle":[],"editor":[{"given":"You-Yang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0170606","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,26]]}}}